G C Viberti
Overview
Explore the profile of G C Viberti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
152
Citations
1953
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Viberti G
Int J Clin Pract
. 2003 Mar;
57(2):128-34.
PMID: 12661797
Rosiglitazone, a potent member of the thiazolidinedione class of oral antidiabetic agents, reduces hyperglycaemia by improving insulin sensitivity--an important underlying factor in the development of both type 2 diabetes and...
12.
De Cosmo S, Tassi V, Thomas S, Piras G, Trevisan R, Perin P, et al.
Nephron
. 2002 Aug;
92(1):72-6.
PMID: 12187087
Unlabelled: Background genetic factors may influence the variability in the rate of progression of kidney disease in type 1 diabetes. In diabetes, progressive mesangial matrix expansion and glomerular sclerosis are,...
13.
Collins A, Vincent J, Newall R, Mitchell K, Viberti G
Diabet Med
. 2001 Nov;
18(11):928-32.
PMID: 11703439
Aims: To compare the performance of the DCA2000 microalbuminuria system for albumin and creatinine concentrations and the albumin:creatinine ratio (ACR) with laboratory measurements in the hospital diabetes clinic and to...
14.
Tagliaferri M, Berselli M, Calo G, Minocci A, Savia G, Petroni M, et al.
Obes Res
. 2001 Apr;
9(3):196-201.
PMID: 11323445
Objective: To evaluate whether subclinical hypothyroidism (SH) affects resting energy expenditure (REE) as well as body composition, lipid profile, and serum leptin in obese patients. Research Methods And Procedures: A...
15.
OHare P, Bilbous R, Mitchell T, O Callaghan C, Viberti G
Diabetes Care
. 2000 Dec;
23(12):1823-9.
PMID: 11128360
Objective: To assess if low (1.25 mg) and/or standard (5 mg) doses of the ACE inhibitor ramipril could prevent progression of microalbuminuria (incipient diabetic nephropathy) in normotensive type 1 diabetic...
16.
Ceriello A, Morocutti A, Mercuri F, Quagliaro L, Moro M, Damante G, et al.
Diabetes
. 2000 Dec;
49(12):2170-7.
PMID: 11118022
There is an individual susceptibility to diabetic nephropathy, and oxidative stress is believed to play an important role in the pathogenesis of diabetic complications. Active oxygen species induce antioxidant enzyme...
17.
Earle K, Mishra B, Morocutti A, Barnes D, Chambers J, Viberti G
J Diabetes Complications
. 2000 Dec;
14(5):277-80.
PMID: 11113691
Microalbuminuria is associated with an increased risk of cardiac death. We assessed whether urinary albumin excretion is related to abnormalities of the QT interval independently of myocardial ischemia. Thirty-four patients...
18.
19.
Minocci A, Savia G, Lucantoni R, Berselli M, Tagliaferri M, Calo G, et al.
Int J Obes Relat Metab Disord
. 2000 Oct;
24(9):1139-44.
PMID: 11033982
Aim: To evaluate whether fat distribution plays a role in determining serum leptin concentrations. Patients And Methods: One-hundred and forty-seven obese patients, 77 males and 70 females, aged 45.1 +/-...
20.
Thomas S, Viberti G
J R Coll Physicians Lond
. 2000 Sep;
34(4):336-9.
PMID: 11005067
No abstract available.